Front Pharmacol. 2017 Apr 05;8:188. doi: 10.3389/fphar.2017.00188. eCollection 2017.

Commentary: A BK (Slo1) channel journey from molecule to physiology.

Frontiers in pharmacology

Domenico Tricarico, Antonietta Mele

PMID: 28424624 PMCID: PMC5380717 DOI: 10.3389/fphar.2017.00188

[No abstract available.]

Keywords: acetazolamide; calcium activated potassium channel; dichlorphenamide; periodic paralysis; skeletal muscle; splicing isoforms

References

1. Neurobiol Dis. 2005 Nov;20(2):296-302 - PubMed
2. Neuromuscul Disord. 2003 Nov;13(9):712-9 - PubMed
3. Pflugers Arch. 1997 Nov;434(6):822-9 - PubMed
4. J Biomech. 2010 Nov 16;43(15):3015-9 - PubMed
5. Front Pharmacol. 2011 Feb 28;2:8 - PubMed
6. Channels (Austin). 2013 Nov-Dec;7(6):442-58 - PubMed
7. FASEB J. 2004 Apr;18(6):760-1 - PubMed
8. Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):4036-41 - PubMed
9. Br J Pharmacol. 2008 May;154(1):183-90 - PubMed
10. Br J Pharmacol. 2003 May;139(2):255-62 - PubMed
11. Pflugers Arch. 2014 May;466(5):875-86 - PubMed
12. Neuromuscul Disord. 2002 Mar;12(3):258-65 - PubMed
13. Clin Transl Sci. 2008 May;1(1):71-4 - PubMed
14. Cell Res. 2008 Aug;18(8):871-8 - PubMed
15. Compr Physiol. 2015 Apr;5(2):761-90 - PubMed
16. PLoS One. 2012;7(7):e40235 - PubMed
17. PLoS One. 2013 Jul 16;8(7):e69551 - PubMed
18. Front Physiol. 2014 Oct 10;5:383 - PubMed
19. Trends Cell Biol. 2001 Sep;11(9):353-8 - PubMed
20. Neurology. 2016 Apr 12;86(15):1408-16 - PubMed
21. Neuromuscul Disord. 2008 Jan;18(1):74-80 - PubMed
22. Age (Dordr). 2014 Feb;36(1):73-88 - PubMed
23. J Physiol. 2010 Mar 1;588(Pt 5):773-84 - PubMed
24. Front Pharmacol. 2016 May 10;7:121 - PubMed

Publication Types

• Journal Article
• Comment